Tom Lanz (Senior Director, Multi-Omics and Biomarkers, Pfizer) explains how AI-powered multi-omics is improving drug safety.

Check out the latest life sciences news in this edition of Week in Brief, where you can learn about all the biggest ...

Ahead of The Festival of Genomics, Biodata & AI in Boston, we’re sitting down with some of our expert speakers […] ...

Endometriosis is a chronic gynecological condition in which tissue similar to the uterine lining grows outside the uterus, most commonly in the pelvis. Affecting millions of women worldwide, the ...

In a recent episode of FoGCast, we sat down with Jillian Hastings-Ward MBE – a leading voice for patient advocacy in genomic medicine. Jillian has spent years ensuring that research stays ethical, ...

Pharmacogenomics has transformed how clinicians reduce adverse drug reactions and optimise therapy. But real-world implementation still faces significant limitations. Can’t make the scheduled session?

Written by Arpita Kulkarni (Director of the Functional Genomics and Bioinformatics Core at HMS/BIDMC). Across the life sciences, a quiet anxiety is growing: what is the role of the experimental ...

The metabolome consists of all the small molecules, or metabolites, which are components and products of biochemical reactions taking place within the body. Given its dynamic nature, metabolomics is a ...

Mark your calendars – The Festival of Genomics & Biodata is returning to Boston in June 2025! Following a hugely successful event last year, we’re thrilled to announce The Festival of Genomics and ...

This feature was written using content from out recenty published Proteomics Playbook, which you can download for FREE here. The sequence of a protein is critical as it largely dictates the protein’s ...

This feature was written using content from our recent Multi-Omics Playbook, which you can download for free here. Last week, we took a look at the power of each of the commonly used omics in the life ...